News

Medical Dialogues1h
Sanofi-Regeneron Dupixent data reinforce use in atopic dermatitis patients with skin of color
Paris: Sanofi has announced that results from the DISCOVER phase 4, single-arm, open-label study assessing Dupixent ...
TipRanks on MSN18h
Regeneron, Sanofi presents results from DISCOVER Phase 4 trial of Dupixent
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent in ...